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Abstract
Background: Although there are different strains of HIV-1 in a chronically infected individual, only one or limited virus
strains are successfully transmitted to a new individual. The reason for this ‘‘transmission bottleneck’’ is as yet unknown.
Methodology/Principal Findings: A human cervical explant model was used to measure HIV-1 transmission efficiency of
viral strains from chronic infections, and transmitter/founder variants. We also evaluated the genetic characteristics of HIV-1
variants in the inoculums compared to those transmitted across the cervical mucosa. Eight different HIV-1 isolates were
used in this study, six chronic isolates and two transmitter/founder viruses. The transmission efficiency of the chronic and
transmitter/founder virus isolates and the viral diversity of chronic isolates before and after viral transmission were assessed.
The results indicate that transmitter/founder viruses did not display higher transmission efficiency than chronic HIV-1
isolates. Furthermore, no evidence for a difference in diversity was found between the inoculums and transmitted virus
strains. Phylogenetic analysis indicated that the sequences of variants in the inoculums and those present in transmitted
virus intermingled irrespective of co-receptor usage. In addition, the inoculum and transmitted variants had a similar
pairwise distance distribution.
Conclusion: There was no selection of a single or limited number of viral variants during HIV-1 transmission across the
cervical mucosa in the organ culture model, indicating that the cervical mucosa alone may not produce the transmission
bottleneck of HIV-1 infection observed in vivo.
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Introduction
Sexual transmission via genital mucosal epithelial surfaces
accounts for more than 80% of HIV-1 infections [1]. A major
gap in our understanding of the mechanism of HIV-1 sexual
transmission is the delineation of molecular events occurring at
early stages of infection. These events are critical in the
establishment of local as well as systemic infection. Recently, by
using single genome amplification (SGA) and ultra-deep sequenc-
ing methodologies, a number of investigators have reported that
HIV-1 and SIV transmission occurs by a single or limited numbers
of R5 tropic transmitted/founder virus variants with a very low
diversity, even though the viral inoculums have a number of highly
diverse variants [2,3,4,5,6,7]. Currently the reasons for such
variant selection during HIV-1 transmission, known as the
transmission bottleneck, are undefined. There exists several
possibilities to explain selection of a single or limited variants
during transmission across the cervical/vaginal mucosa: a) the
mucosa exerts a selection pressure on the transmitted/founder
virus, b) there is competitive selection among transmitted variants
as they traverse through mucosa to the regional lymph node and
then to systemic compartments, or c) transmission of a single or
limited variants from the mixture of quasispecies in the inoculums
may occur in a stochastic fashion.
Evaluating the role of cervical mucosa at very early events of
HIV-1 transmission is difficult to perform in humans. Although
the SIV/macaque model has been used for this purpose, this
animal model may not accurately reflect HIV-1 infection of
humans at mucosal surfaces. To circumvent this problem, we have
developed a cervical tissue-derived organ culture model to study
HIV-1 transmission across the cervical mucosa isolated from
women [8]. Unlike cell lines, this model provides the natural tissue
architecture, including epithelial cells, submucosa, and immune
cells such as T cells, macrophages (mW) and Langerhans cells (LC),
and allows for the evaluation of transmission of infectious cell-free
and cell-associated HIV-1 across the mucosa. Detailed studies
have documented that the HIV-1 transmission observed in this
organ culture are highly specific and not due to nonspecific
leakiness in the tissue explant. These data include: i) lack of any
discontinuity of the basal layer of the tissue during culture as
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sion across the mucosa of blue dextran, a polysaccharide of
2610
6 Da molecular weight (smaller than HIV-1 virions) and
fluorescent beads of 7.2 micron (similar size to HIV -1 particles),
and iii) lack of mucosal transmission by UV and heat inactivated
HIV-1 [8,9] We have also examined the cervical tissue integrity
during in vitro culture. Hematoxylin and eosin staining of the
paraffin embedded tissue at various times after cultivation
indicated that the stratified squamous epithelial layers and
especially the basal layer of cells remained largely unchanged
after culture [8]. The cellular functions of the tissues during the
culture period were also assessed by quantitative immunohisto-
chemical analysis for three immune cell markers (CD45RO for
memory T lymphocytes, S100 for dendritic cells, and CD68 for
macrophages), as well as two non-immune cellular markers
(cytokeratin as a differentiation marker of the epithelial cells and
Ki67 as a cell proliferation marker [10,11,12]). The levels of these
five cellular markers remained unchanged during cultivation in
both mock-exposed and HIV-1-exposed tissues, indicating the
tissues are functionally active.
Using this cervical tissue-based organ culture we have shown
that CD4+T cells are the first cells that become infected within
6 hr of exposure of cervical tissue to HIV-1. Thereafter, HIV-1
infected macrophages and dendritic cells were detected after 1 and
3 days of infection, respectively [9]. Using simultaneous in situ
hybridization and immunophenotyping techniques, HIV-1 ex-
pressing CD4+ T lymphocytes, macrophages, and dendritic cells
are detected at the intraepithelial layer within 3 days of infection,
as observed in SIV/macaque system at early stages of infection
[9]. Furthermore, the initial small pool of infected CD4+cells
observed at 6 h post infection is amplified 10-fold within 24–96 h.
Within this same time frame, more infected cells are detected in
the submucosa and in the intraepithelial layer. Thus, this pattern
of infection in the organ explant model is very similar to infection
pattern reported in experimental infections of macaques by SIV
[13,14]. Finally, we and others have shown that HIV-1
transmission through cervical mucosa in the organ culture is
inhibited by HIV-1 RT and entry inhibitors. These latter
properties formed the basis for using this type of organ culture
to evaluate various anti-HIV-1 microbicides by us and a number
of investigators [6,15,16,17,18]. Therefore, the cervical tissue
based organ culture can serve as a useful and informative model
for HIV-1 transmission in humans.
In this report we have used this well established and validated
organ culture model to delineate the role of cervical mucosa in
selection of viral variants in HIV-1 transmission. Our data indicate
that the cervical mucosa alone does not appear to have a
significant role in the characteristic restrictive selection of HIV-1
variants that leads to the observed extremely low diversity of viral
infection after mucosal exposure.
Materials and Methods
Ethics Statement
The cervical tissues for the organ culture were harvested from
patients who undergo routine hysterectomy or anterior/posterior
procedures at the Magee Women Hospital (MWH) of the
University of Pittsburgh Medical Center. All tissues were obtained
through the Tissue Procurement Facility of the hospital. This
study was approved as an Exempt Study by the Institutional
Review Board of the University of Pittsburgh. Individual informed
consent was waived because this study used routinely procured
tissue from patients through the Tissue Procurement Facility
without any patient identification. No patient was specifically
enrolled for this purpose. No specific racial or ethnic distribution
was sought during the collection of tissue.
Viruses
Eight different HIV-1 isolates were used in this study, including
one HIV-1 subtype A (RW92008) from Africa, four HIV-1
subtype B (two R5 tropic and two X4 tropic), one HIV-1 subtype
C R5 (IN93999) from India, and two transmitted/founder R5
viruses from an acute HIV-1 infection study (CH040 and CH058)
[19]. Of the 4 subtype B isolates, two are laboratory strains (IIIB
and BAL) and two are clinical isolates (015 and 074) that were
obtained from the Multicenter AIDS Cohort Study (MACS).
Africa subtype A (RW92008), Indian subtype C (IN93999) viral
isolates, and two plasmids DNA containing the infectious
molecular clones of transmitter/founder viruses (CH040 and
CH058) were obtained from the NIH AIDS Research and
Reference Reagent Program. Viruses from infectious clones were
generated from transfection of 293T cells. All viruses were grown
in PHA-stimulated CD8-depleted PBMC, and their infectivity
titers were determined in CD8-depleted PBMC.
Cervical Organ Culture
The organ culture was performed with cervical tissues from
HIV negative premenopausal women, as previously described
[8,20]. The selected cervical tissues did not have any sign of
precancerous lesions, and the donor women tested negative for
sexually transmitted infections. Briefly, a 6 mm biopsied cervical
tissue explant was placed into a transwell with the epithelial layer
oriented upwards and sealed around its perimeter with 3%
agarose. The tissue containing transwell was then placed into a 12-
well plate containing 1 ml of RPMI-1640 media supplemented
with 10% FBS. To measure the transmission across the cervical
mucosa, cell-free HIV-1 in culture medium (BAL, IIIB, 015, 074,
RW92008, IN93999, CH058C or CH040C with TCID50 values
described in Table 1) was added to the top of the tissue in the
upper chamber. In the case of mixed infections (e.g., HIV-1 BAL
and transmitter/founder viruses or HIV-1 BAL and EIAV), the
inoculums of transmitting pairs were diluted appropriately to
achieve 1:1 ratio of the two strains with respect to TCID50 or viral
RNA copies. A transwell with the membrane only served as a
positive control, while a transwell with agarose only served as a
negative control. Cultures were incubated at 37uC for 3 days in a
CO2 incubator. Transmission from each virus was tested in tissues
from 1–2 donors with at least triplicate tissue biopsies from each
tissue donor. On the third day, the tissue was removed, and the
culture supernatants in the bottom chamber and the original viral
inoculum were centrifuged at high speed (22,000 rpm) in a
Biofuge Stratos centrifuge (Sorvall Instrument) to pellet virions.
RNA was then extracted from the pelleted virus for the analyses of
viral RNA concentration and diversity, before and after viral
transmission. The levels of strain specific HIV-1 RNA species in
single or mixed infections were quantitated using TaqManH real-
time PCR using primers specific for the respective viral strain. To
ensure that transmitted viruses were not due to leaks in the system,
the intactness of the tissues were evaluated at the end of each
experiment by examining the transmission of blue dextran through
the tissue and agarose control wells. These assays confirmed that
the amount of blue dextran transmitted through the tissue well was
equal or lower than that in the agarose control well. The
transmission efficiency through cervical explants was calculated by
dividing the number of viral RNA copies that were detected in the
bottom well supernatant by the number of viral RNA copies
detected in the supernatant of the membrane-only well and
multiplying by 100%.
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For sequence analysis, total RNA was extracted from the viral
pellets and subjected to reverse transcription. The primer for
reverse transcription was ED12 59-AGTGCTTCCTGCTGCTC-
CCAAGAACCCAAG (7782–7811*), and the primers for nested
PCR were: first round forward primer: ED31 59-CCTCAGC-
CATTACACAGGCCTGTCCAAAG (6811–6845*), reverse
primer: BH2 59-CCTTGGTGGGTGCTACTCCTAATGGTT-
CA (7725–7697*), second round forward primer: DR7 59-TCA-
ACTCAACTGCTGTTAAATGGCAGTCTAGC (6990–7021*),
reverse primer: DR8 5-CACTTCTCCAATTGTCCCTCATAT-
CTCCTCC (7668–7638*). (*the positions are based on HIV-1
HXB2 strain). Single genome amplification was performed as
described previously [3,5]. Amplicons were directly sequenced in
an ABI Prism 3700 DNA Sequencer. Vector NTI software was
used to inspect the chromatograms. The sequences without mixed
bases were taken as an evidence of single genome amplification
from a single viral RNA/cDNA template. DNA alignments were
constructed using CLUSTAL X alignment program and hand
adjusted when necessary. The sequences were visually inspected
by using neighbor-joining phylogenies implemented in MEGA5.0
[21] to test the potential bottleneck during the variants across the
mucosa.
Two quantitative methods, Slatkin-Maddison and diversity
analysis were further employed to evaluate the effect of the cervical
mucosa on viral transmission. A cladistic method of Slatkin-
Maddison analysis [22,23] implemented in the HyPhy [24] pro-
gram was used to assess the possible enrichment of the transmitted
HIV variants. A phylogenetic tree was constructed for each
inoculum and transmitted viral pairs. The number of migration
events needed to postulate the observed spatial distribution of
HIV-1 sequences in the phylogenetic trees was estimated. The null
model of this analysis is that all the sequences from the transmitted
variants would be as likely to be related to the inoculum as to
themselves. The frequency of distribution under this null model
was obtained by constructing 10,000 random trees made by
random joining/splitting of the ‘true’ phylogenetic tree. The
number of migration events on the true tree was then compared to
the null distribution, and the probability that the true tree came
from a population lacking similarity was determined. If there was
variant selection during transmission across the mucosa and if the
similar number of the inoculum and transmitted viral sequences
were randomly selected, the transmitted viral sequences should
trend to cluster together. Also, the number of migration events
should be smaller compared with the random joining/splitting
phylogenetic tree. The tests were performed with all viral
sequences and after the removal of identical sequences, as these
sequences can increase both the frequency of compartmentaliza-
tion calls and the statistical support for those calls. The sequence
enrichment was considered statistically significant if fewer steps
were seen in the true tree than in 95% of the random trees. In
addition, the neighbor-joining method was utilized for the diversity
analysis as measured in MEGA5.0. Statistical comparisons of
diversity between the inoculum and the transmitted variants were
performed using the two-sample tests (Tsubjmean test) for




The HIV-1 env nucleotide sequence data were deposited in the
Genbank nucleotide sequence.
Databases using Sequin V5.35 (http://www.ncbi.nlm.nih.gov/
Sequin/), under the following.
Accession numbers: JN415236–JN415469.
Results
Comparison of transmission efficiency between the
founder/transmitter and chronic HIV-1 isolates
In our previous studies we have provided substantial evidence
that HIV-1 transmission observed in the organ culture is highly
specific and cannot be attributed to leakiness in the system. To
further substantiate the specificity of HIV-1 transmission in this
organ culture model, we compared the transmission of HIV-1
BAL with equine infectious anemia virus (EIAV), an equine
lentivirus similar in size to HIV, but unable to infect human cells.
Thus, the EIAV serves as a highly relevant control for nonspecific
transmission across human cervical mucosa tissues. As shown in
Table 2, exposure of the cervical tissue explants to EIAV produced
a viral transmission level that was less than 0.0001%, a value that
was similar to the EIAV transmission observed in the agarose
control, indicating a lack of specific transmission of the EIAV
through the cervical tissue. In marked contrast, exposure of the
cervical tissue explants to an HIV-1 BAL yielded a transmission
efficiency of 0.32%, or about 1000-fold higher than observed with
EIAV, despite the use of similar inoculum doses of 5610
7 RNA
copies of each virus. Furthermore, when a mixed inoculum of
EIAV and HIV-1 at a ratio of 1:1 (by RNA content) were used to
infect the cervical explant, the transmission efficiency of EIAV was
observed to be less than 0.0002% compared to the HIV-1 BAL
transmission efficiency of 0.25%. Taken together, these results
conclusively demonstrate that HIV-1 transmission in the cervical
tissue based organ culture is highly specific therefore, can be
Table 1. Characteristics of Viral Inoculums Used in the HIV-1 Transmission and Diversity Studies.
Viral Isolates Origin of Isolate Co-Receptor Usage Clade Viral Inoculum (TCID50)
IIIB Laboratory X4 B 1610
5
Bal Laboratory R5 B 1610
6
015 Clinical R5 B 1.2610
5
074 Clinical X4 B 6.2610
3
CH058 Transmitter/Founder R5 B 3.1610
4
CH040 Transmitter/Founder R5 B 6.2610
3
RW92008 African X4 A 8.1610
3
IN93999 Indian R5 C 2.5610
2
doi:10.1371/journal.pone.0032539.t001
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mucosa [8].
Having validated the specificity of HIV-1 transmission in the
organ culture system, we next sought to evaluate the role of
cervical mucosa during HIV-1 transmission by comparing the
transmission efficiencies of reference clinical isolates from different
HIV clades (A, B, and C), of different tropisms (R5 or X4), and of
transmitted/founder viruses characterized in an acute infection
study [19]. The dose of the inoculum for each virus isolate was
shown in Table 1. Using the cervical organ culture model, the
transmission efficiency of each virus strain was determined as
described in Materials and Methods. As shown in Figure 1, the
transmission efficiency of the six reference clinical isolates ranged
from 0.005% to 3.12% (median 0.332%). Although there were
variations in transmission among different isolates, there were no
apparent significant differences in transmission efficiency levels
among different virus isolates that are R5 and X4. Furthermore,
the results indicate that the viral inoculum size does not have a
significant influence on the observed transmission efficiency
(compare Table 1 and Figure 1). For example, the highest
transmission efficiency (3.12%) was observed with the 074 clinical
isolate at a dose of 6.2610
3 TCID50, while one of the lowest
transmission efficiencies (0.332%) was observed with the BAL
isolate at a higher dose of 1610
6 TCID50.
Since the transmission properties of related transmitted/founder
viruses are of great interest to understand HIV-1 transmission, we
examined whether the transmitted/founder viruses reported in an
acute HIV-1 infection study [19] have any selective advantage of
viral transmission across the cervical mucosa. For this purpose, we
first examined the viral transmission efficiency individually of the
two transmitted/founder viruses CH040 and CH058. The
transmission efficiency of the two transmitted/founder variants
(CH040 and CH058) were 0.56% and 0.26%, respectively
(Figure 1). These transmission efficiency values are similar to the
transmission efficiency levels observed above for chronic and lab
viral isolates. Therefore, the transmitted/founder viruses do not
appear to have higher transmission efficiency than those non-
transmitted/founder HIV-1 variants.
Next, we examined whether CH040 and CH058, being
transmitted/founder viruses, have a transmission advantage over
a non- transmitted/founder HIV-1, such as HIV-1 BAL, in a
competitive transmission assay, as described previously [20]. For
this purpose, equal TCID50 amounts of CH040 or CH058 were
mixed with HIV-1 BAL and used as inoculum in the organ culture
system. Transmitted HIV-1 contained in culture supernatant was
analyzed for the relative levels of CH040 or CH058 and BAL
viruses by a real-time PCR using the primers/probes set that can
discriminate between transmitted/founder virus and BAL. As
shown in Table 3, these results from the BAL/CH040 pairwise
competition indicated that transmission efficiencies were 1.72%
for HIV-1 BAL and 1.68% for the transmitted/founder strain
CH040. Similarly, in the BAL/CH058 pairwise competition assay,
the transmission efficiency for HIV-1 BAL was 0.44%, while the
transmission efficiency for the transmitted/founder strain CH058
was 0.63%. Thus, the transmitted/founder viruses do not appear
to have any competitive advantage over other viral isolates in their
transmission efficiency through cervical mucosa.
Table 2. Transmission of EIAV and HIV across cervical mucosa
in an organ culture.
Vial Inoculum Transmission efficiency(%)*
HIV BAL 0.32
EIAV ,0.0001
Agarose control for HIV ,0.0001




*Denotes transmission efficiency of HIV or EIAV RNA from a mixture of EIAV and
HIV(1:1) inoculum. Transmission efficiency was calculated as described in the
materials and methods section.
doi:10.1371/journal.pone.0032539.t002
Figure 1. The transmission efficiencies of various HIV-1 inoculums across the cervical mucosa. The transmission efficiencies were
calculated as the percentage of the viral load in the inoculums that were transmitted across cervical mucosa. X axis denotes the isolates (co-receptor
usage indicated in the parenthesis) used in this study while Y axis denotes the percentage of the transmission. Data shown here is the average of 3
biopsies with standard error. Isolates are grouped as chronic isolates and transmitter/founders.
doi:10.1371/journal.pone.0032539.g001
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those present in transmitted virus
To evaluate transmission characteristics of transmitted HIV-1
variants, we analyzed HIV-1 sequences of transmitted viruses
across the cervical mucosa using SGA to minimize the potential
for template switching during the PCR reaction and re-sampling
because of unequal template amplification and cloning in vitro [5].
Each amplicon was directly sequenced in the variable C2–V5
region of HIV-1 envelope. A total of 230 env C2-V5 gene
sequences were generated by SGA from the starting inoculums
and from the viruses transmitted across the cervical mucosa. A
median of 18 sequences per isolate (range 15–20) was used for
subsequent analysis. Neighbor-joining phylogenetic trees were
constructed using the sequences from all six inoculum/transmis-
sion pairs. For all of the variants, the inoculum sequences were
heterogeneous, consistent with their derivation from chronically
infected individuals (Figure 2). Importantly, the transmitted
variant sequences (red) were quite similar to that of the inoculum
variant sequences (green), which were heterogeneous and
intermingled in the inoculum sequences (Figure 2). These data
clearly indicate that multiple inoculum quasispecies were trans-
mitted through the cervical mucosa in the organ culture.
We then examined the phylogenetic relationships of env
sequences between viral inoculums and their corresponding trans-
mitted viruses individually in a neighbor-joining tree (Figure 3).
When HIV-1 IIIB was used as the inoculum, the transmitted viral
sequences (black dots) were intermingled with those of the
inoculum quasipecies (black circles), and almost all the lineages
in the inoculum could be found in the transmitted variants
(Figure 3A). The phylogenetic analysis was then extended to the
paired sequences of HIV-1 variants in inoculums and those
present in transmitted viruses for HIV-1 BAL (Figure 3B), clinical
isolate 015 (R5) (Figure 3C), clinical isolate 074 (X4) (Figure 3D),
the subtype A RW92008 (Figure 3E) and the subtype C IN93999
(Figure 3F). The results were quite similar to that of HIV-1 IIIB in
that the phylogenetic analyses of all of these pairs failed to detect
distinct genetic differences between the inoculums and the
transmitted viral variants. Taken together, these phyologentice
studies indicate a lack of selection in the transmission of diverse
laboratory and clinical HIV strains across the cervical mucosa.
Diversity analysis of the inoculums and transmitted HIV-1
variants
To further compare the genetic characteristics of viral variants
in inoculums and transmitted virus populations, the viral diversity
analysis was also performed according to the paired sequence
distances. Mean intra-viral diversity ranged from 0.2% to 1.45%
for the inoculums and from 0.2% to1.6% for the transmitted
variants, respectively (Figure 4). Viral diversity was not statistically
significant (p.0.05) between the inoculums and transmitted
viruses (Figure 4A–F) in 5 of 6 isolates, regardless of their subtypes
and co-receptor usage. However, in the case of HIV-1 BAL, the
diversity of transmitted virus was significantly decreased compared
to that of the inoculums (Figure 4B), but it was still much higher
than one would have expected from the transmission of a single
viral variant, as observed in human and monkey infections [3,4].
Although the diversity of the subtype A and C inoculums
(Figure 4E, F) was lower compared to that of subtype B, there
was still no significant difference in diversity between inoculums
virus and transmitted virus populations. In addition, a cladistic
method of Slatkin-Maddison analysis [22,23] was also used to
assess the possible enrichment of the transmitted HIV variants.
The tests were performed with all viral sequences, and after
removal of identical sequences. The results of Slatkin-Maddison
analyses are shown in Table S1. These data indicate no significant
enrichment in the transmitted viral strains in 4 of 6 isolates.
However, for HIV-1 BAL there was a significant trend of
enrichment in transmitted variants, regardless whether the
identical sequences were removed or not for the analysis. For
HIV-1 074 strain, there was a significant trend of enrichment in
the transmitted virus when the test was performed with all viral
sequences, but, the enrichment was not significant when the
identical sequences were removed (Table S1). These data
demonstrate that the diversity and Slatkin-Maddison analyses
yielded comparable conclusions. Although there was a 10–100 fold
difference in infectivity of viral inoculums used for the different
viral isolates (Table 1), the current analyses did not reveal extreme
low diversity in any of the virus populations transmitted in our
organ culture system, a result that is in distinct contrast to the low
diversity detected in viral populations transmitted in humans or
monkeys [2,3,4,5,6].
To further examine the role of inoculum size on the selection of
transmitted virus and hence diversity in the transmitted virus
population, we inoculated cervical tissue in our organ culture with
a serial half log decreasing dose of HIV-1 BAL and measured viral
diversity in the transmitted virus population. Each inoculum was
tested in 3 biopsies, and the whole experiment was conducted with
biopsies from a single donor to rule out possible effects from
patient variation. The results shown in Table 4 indicate that the
transmission rate is quite similar with all inoculums and that there
is no significant difference in viral diversity between inoculums and
the transmitted variants generated from the different dilutions of
inoculum.
The analysis of pairwise distance distribution of the transmitted
variants can reflect the transmitted viral genetic characteristics and
display the effect of the minor diverse variants when comparing
the paired viral diversity. In general, the inoculum and transmitted
pairs displayed a similar pairwise distribution (Figure 5A–F)
Table 3. The competition analysis of the transmission efficiency for the transmitted/founder viruses and chronic HIV-1 isolates.
Viral pairs Variant(co-receptor) Inoculum viruses (TCID50) Transmission efficiency*








HIV-1 CH040 and CH058 are transmitted/founder viruses and HIV-1 BAL is a chronic isolate.
*The transmission efficiency was calculated by dividing the viral RNA copies in the inoculum with the viral RNA copies of the transmitted variants from the bottom wells.
Real-time RT PCR with specific primers/probes set which could discriminate CH040, CH058 and BAL viruses was employed.
doi:10.1371/journal.pone.0032539.t003
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case of the BAL infection, however, the transmitted viral diversity
shifted slightly left (Figure 5B), indicating that there was a trend
towards selection during BAL transmission. However, according
to the distribution, there were still multiple quasispecies in the
transmitted of BAL variants.
Discussion
Previous studies [4,6] with acutely infected monkeys demon-
strated that from an inoculum containing numerous SIV viral
variants, only one quasispiecies or a limited number of variants
crossed the cervical mucosa and established infection in the
recipient host. Similar transmission of a single R5 tropic HIV-1
variant has also been reported during sexually transmitted
infection in human [3]. The mechanism for transmission of single
or a limited number of HIV-1 variant viruses is not clear. We
reported earlier that cervical mucosal organ culture could serve as
model to study HIV-1 transmission across cervical mucosa [8,9]
.There are potential limitations in using organ culture to study the
role of cervical mucosa in the transmission bottleneck of HIV-1: 1)
an adaptive immune response acting on behalf of both partners in
the transmission event is absent in organ culture, 2) mucosal
secretions often present in vivo on cervical surface are mostly absent
in organ culture. These secretions can be important because of
their capacity to trap or inactivate infecting virions. However,
transmission profiles using the organ culture are remarkably
similar to those reported for SIV/macaque system with regard to
types of cells that become infected and their localization in cervical
tissue, and the expansion of the initial pool of infected cells during
Figure 2. Phylogenetic analysis of all viral inoculum and transmitted pairs. C2-V5 of env nucleotide sequences of the inoculum and
transmitted HIV-1 species were aligned for all linked inoculum variants (green lines) and transmitted variants (red lines) and a neighbor-joining tree
representing different transmission pairs. Branch lengths are drawn to scale. Viral strain names are shown on the branches, and asterisks are indicated
on branches with bootstrap values greater than 99%.
doi:10.1371/journal.pone.0032539.g002
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culture to study the role of cervical mucosa in HIV-1 transmission
bottleneck infection, because both the inoculum and transmitted
variants can be accurately analyzed. Furthermore, by using the
organ culture, we can focus on the specific role of the mucosal
tissue in HIV-1 transmission bottleneck without confounding
factors such as mucus, immune responses, etc. Sequence analysis
of the transmitted virus isolated from the acute phase of infection
in monkey or human indicated that the transmitted variants
formed unique monophyletic or limited clusters in the phyloge-
netic tree [3,4,6]. In these studies it has been speculated that the
mucosa might play an important role in viral variant selection.
However, in the study reported here, phylogenetic trees (Figures 2
and 3) clearly demonstrated that the inoculum and the transmitter
variants were intermingled, suggesting that most of the inoculum
variants were transmitted across the cervical mucosa. The diversity
and pairwise distance distribution analysis (Figures 4 and 5)
indicated no statistical differences between the inoculum and
transmitted variant populations. The current results also indicate
that the lack of difference in diversity between the inoculum and
transmitted variants is not due to inoculum size (Table 4).
Consequently, the number of founders in our study was much
higher than the limited number of founder virus reported in vivo
[3,4,19]. These results support the idea that mucosa alone may not
Figure 3. Neighbor-joining trees of HIV-1 env C2-V5 sequences individually from six inoculum and transmission pairs. Aligned
nucleotide sequences for six inoculums and transmitted variants were used to generate neighbor-joining trees for individual viral pairs. (A) HIV-1
subtype B, IIIB; (B) HIV-1 subtype B, BAL; (C) HIV-1 subtype B, clinical isolate 074; (D) HIV-1 subtype B, clinical isolate 015; (E) HIV-1 subtype A,
RW92008; (F) HIV-1 subtype C, IN93999. White circles: the sequences of the inoculum viruses; black circles: the sequences of the transmitted viruses.
doi:10.1371/journal.pone.0032539.g003
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HIV-1 transmission.
This notion was further verified by comparing the transmission
efficiency of HIV-1 isolates both from chronically infected subjects
and from the transmitted/founder HIV-1 obtained during the
acute stage of infection. Our data on the transmission efficiency
among these isolates and direct competition analyses indicate that
the transmission efficiency both of the chronic variants and the
transmitted/founder variants were quite low, and that the
founder/transmitter variants did not have a selective advantage
of transmission over chronic HIV-1 isolates. Since each isolate was
tested in different tissues in triplicate, the source of tissue did not
seem to influence the efficiency of transmission. The low
transmission efficiency levels observed in our organ culture system
are consistent with the low transmission (0.01 to 0.001%) observed
in SIV/macaque model, as reported by Miller et al. [26].
The current study using the organ culture suggests that cervical
mucosa alone may not play a role in the transmission bottleneck
observed in vivo. Furthermore, since most of the HIV-1 sequences
in semen, the major vehicle in HIV-1 transmission are R5 tropic
[27,28,29,30,31] and transmitting donors are mostly asymptom-
atic, it is expected that transmitting HIV-1 would be predomi-
nantly R5 tropic. Therefore, there may not be a need for any
special mechanism for the transmission of R5 tropic viruses, as
suggested by some investigators [32,33,34]. In addition, previous
studies did not find any stretch of signature sequences in
transmitted viruses [2,3,4,5,6]. Therefore, HIV-1 transmission of
a single variant of R5 with no signature sequence can be best
explained by the idea that HIV/SIV transmission is mostly a
Figure 4. Diversity analysis of the six HIV-1 isolates before and after their mucosal transmission. Diversity analysis of envelope
sequences (C2–V5) from different isolates was performed using MEGA5.0 software. Nucleic acid intra-population diversity was calculated based on
nucleotide sequences. The differences between the diversity were plotted as intra-population distances as a function of inoculums and transmitted
viruses. Statistical significance of the diversity differences between the inoculums and transmitted viruses was performed using two-sample tests [25].
(A) HIV-1 subtype B, IIIB; (B) HIV-1 subtype B, BAL; (C) HIV-1 subtype B, clinical isolate 074; (D) HIV-1 subtype B, clinical isolate 015, (E) HIV-1 subtype A,
RW92008; (F) HIV-1 subtype C isolate, IN93999.
doi:10.1371/journal.pone.0032539.g004
Table 4. Measurement of the transmitted HIV-1 IIIB diversity













The viral diversity of the viral inoculum is 1.2060.09%.
*No significant difference in viral diversity between the inoculum and all the
three different transmitted variants.
doi:10.1371/journal.pone.0032539.t004
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which concluded that all of the sequences in the inoculum are
probable to be transmitted to the recipient [4,6]. However, a
recent study on the analysis of HIV-1 variants of transmitter-
recipient pairs indicates selection for a transmitting virus variant
with a set of essential biological properties, such as fewer
glycosylation sites, more compact envs, and a histidine residue at
position 12 of the leader sequence of the env protein [35].
Therefore, other possibilities should also be considered: (i) it is
possible that the mucosal immune system acts as a net, and the
immune environment of the explant is different from in vivo
infection; and (ii). The selection of viral variants occurs at the
regional draining lymph nodes after crossing the cervical
mucosal. Further studies related to the genetic bottleneck during
HIV-1 and SIV transmission are warranted to support such a
contention.
All of the founder virus-related studies with SIV reported in the
literature [4] and the current HIV transmission studies have been
performed with cell-free virus. However, transmission could occur
via both cell-free and cell associated HIV-1/SIV, although
transmission via cell-associated SIV was found to be much less
efficient than cell-free virus [36,37]. It is difficult to predict
accurately the outcome of founder virus from cell-associated virus.
Sexual transmission of HIV-1 mostly occurs via semen which
contains both cell-free and cell-associated HIV-1. Since a limited
number of founder virus strains were observed in sexually
transmitted HIV-1 presumably via semen, a limited number of
virus transmissions from cell-associated HIV-1 probably occur in a
similar manner to cell-free HIV-1. Further study with cell-
associated SIV in a macaque model would be useful to further
define the pattern of cell-associated virus transmission compared
to cell free virus transmission.
Figure 5. Comparison of distance distribution between the inoculums and the transmitted viral sequences. The distance distribution
for the inoculums and transmitted pairs was shown in pairwise distance histogram. For each pair, the distances between every possibility of pair
sequences of inoculums and transmitted variants were calculated respectively. (A) HIV-1 subtype B, IIIB; (B) HIV-1 subtype B, BAL; (C) HIV-1 subtype B,
clinical isolate 074; (D) HIV-1 subtype B, clinical isolate 015; (E) HIV-1 subtype A, RW92008; (F) HIV-1 subtype C, IN93999. Black needle bars represent
the inoculums pairwise viral sequence distance frequency. Red needle bars represented the transmitted pairwise viral sequence distance frequency.
doi:10.1371/journal.pone.0032539.g005
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